Celltrion, Inc. (KRX:068270)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	38,381,264	40,365,453	27,970,378	23,000,359	27,592,583	48,989,351
Market Cap Growth	-8.46%	44.31%	21.61%	-16.64%	-43.68%	102.64%
Enterprise Value	39,782,678	41,523,072	28,600,944	23,312,921	27,515,085	48,962,928
Last Close Price	174100.00	180288.46	183802.26	146015.57	172836.27	306163.48
PE Ratio	76.05	95.50	52.22	42.77	47.62	94.62
Forward PE	36.47	48.86	76.81	41.12	52.71	74.26
PS Ratio	10.48	11.35	12.85	10.07	14.57	26.49
PB Ratio	2.22	2.30	1.63	5.38	6.81	14.29
P/TBV Ratio	7.92	7.86	5.54	5.99	7.67	16.50
P/FCF Ratio	44.97	52.64	85.51	-	32.55	185.75
P/OCF Ratio	39.23	44.76	52.07	26635.21	30.28	139.67
PEG Ratio	-	1.00	2.80	2.44	1.54	2.00
EV/Sales Ratio	10.86	11.67	13.14	10.21	14.53	26.48
EV/EBITDA Ratio	40.66	45.62	31.88	26.69	28.71	54.87
EV/EBIT Ratio	64.09	84.39	43.91	36.02	36.98	68.14
EV/FCF Ratio	46.62	54.15	87.44	-	32.46	185.65
Debt / Equity Ratio	0.13	0.13	0.11	0.19	0.18	0.23
Debt / EBITDA Ratio	2.27	2.41	2.11	0.91	0.78	0.87
Debt / FCF Ratio	2.62	2.86	5.78	-	0.88	2.94
Asset Turnover	0.18	0.17	0.17	0.40	0.35	0.42
Inventory Turnover	0.63	0.65	0.62	2.10	1.68	2.38
Quick Ratio	0.64	0.75	0.68	1.72	1.94	1.91
Current Ratio	1.61	1.75	1.98	2.26	2.54	2.38
Return on Equity (ROE)	2.95%	2.41%	5.04%	12.77%	15.67%	16.69%
Return on Assets (ROA)	1.90%	1.50%	3.15%	7.00%	8.70%	10.12%
Return on Capital (ROIC)	2.02%	1.58%	3.38%	8.20%	10.34%	11.87%
Return on Capital Employed (ROCE)	3.60%	2.80%	3.70%	14.10%	16.70%	18.10%
Earnings Yield	1.33%	1.05%	1.92%	2.34%	2.10%	1.06%
FCF Yield	2.22%	1.90%	1.17%	-0.48%	3.07%	0.54%
Dividend Yield	0.40%	0.38%	-	-	-	-
Payout Ratio	31.50%	24.51%	9.64%	19.05%	0.00%	-
Buyback Yield / Dilution	-28.04%	-44.80%	0.86%	1.09%	-0.07%	-0.19%
Total Shareholder Return	-27.65%	-44.42%	0.86%	1.09%	-0.07%	-0.19%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.